Basic Information
Basic information for SNHG14-280-11aa-5
Peptide Name SNHG14-280-11aa-5
Genome Position chr15:25118301-25118333[+]
Species Human
Peptide Sequence MLSANSQNNTP
Peptide Length 11
Unique No (SNHG14-210-11aa-2,SNHG14-218-11aa,SNHG14-223-11aa,SNHG14-224-11aa-9,SNHG14-227-11aa-4,SNHG14-230-11aa-5,SNHG14-231-11aa-2,SNHG14-232-11aa-5,SNHG14-235-11aa-5,SNHG14-236-11aa-3,SNHG14-238-11aa-3,SNHG14-239-11aa-2,SNHG14-242-11aa-4,SNHG14-248-11aa-4,SNHG14-249-11aa-4,SNHG14-251-11aa-4,SNHG14-254-11aa-6,SNHG14-255-11aa-6,SNHG14-257-11aa-4,SNHG14-263-11aa-4,SNHG14-268-11aa-4,SNHG14-269-11aa-6,SNHG14-270-11aa-11,SNHG14-272-11aa-3,SNHG14-274-11aa-2,SNHG14-275-11aa-7,SNHG14-276-11aa-5,SNHG14-277-11aa-5,SNHG14-278-11aa-3,SNHG14-279-11aa-3,SNHG14-281-11aa-5,SNHG14-282-11aa-6,SNHG14-283-11aa-5,SNHG14-287-11aa-6,SNHG14-288-11aa-5,SNHG14-289-11aa-2,SNHG14-293-11aa-2,SNHG14-297-11aa-5,SNHG14-298-11aa-4,SNHG14-300-11aa-2,SNHG14-301-11aa-5,SNHG14-302-11aa-2,SNHG14-303-11aa-4,SNHG14-304-11aa-3,SNHG14-309-11aa-6,SNHG14-311-11aa-5,SNHG14-312-11aa-5,SNHG14-313-11aa-7,SNHG14-314-11aa-2,SNHG14-315-11aa-5,SNHG14-318-11aa-4,SNHG14-319-11aa-2,SNHG14-321-11aa-3,SNHG14-322-11aa-5,SNHG14-323-11aa-6,SNHG14-324-11aa-7,SNHG14-325-11aa-4,SNHG14-330-11aa-2,SNHG14-332-11aa-6,SNHG14-333-11aa-5,SNHG14-334-11aa-6,SNHG14-335-11aa-4,SNHG14-338-11aa-1,SNHG14-340-11aa-3,SNHG14-342-11aa-3)
Grand Average of Hydropathicity -0.9455
Relative Molecular Mass 1356.45
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000662370;SNHG14-280
Transcript Length 7537
Coding Ability 0.4144
DNA Sequence Corresponding to Peptide ATGTTATCAGCAAATTCCCAAAACAACACCCCT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :